PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 262 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $144 | -64.9% | 5 | -64.3% | 0.00% | – |
Q1 2024 | $410 | -13.3% | 14 | 0.0% | 0.00% | – |
Q4 2023 | $473 | -74.3% | 14 | -69.6% | 0.00% | – |
Q2 2023 | $1,844 | -73.3% | 46 | -72.8% | 0.00% | -100.0% |
Q1 2023 | $6,897 | +54.0% | 169 | +45.7% | 0.00% | +100.0% |
Q4 2022 | $4,479 | -10.4% | 116 | +17.2% | 0.00% | -50.0% |
Q3 2022 | $5,000 | -37.5% | 99 | -26.7% | 0.00% | 0.0% |
Q2 2022 | $8,000 | 0.0% | 135 | +25.0% | 0.00% | 0.0% |
Q1 2022 | $8,000 | -11.1% | 108 | -28.5% | 0.00% | 0.0% |
Q4 2021 | $9,000 | +28.6% | 151 | +24.8% | 0.00% | 0.0% |
Q3 2021 | $7,000 | 0.0% | 121 | +3.4% | 0.00% | 0.0% |
Q2 2021 | $7,000 | -22.2% | 117 | -7.9% | 0.00% | -33.3% |
Q1 2021 | $9,000 | +12.5% | 127 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $8,000 | +300.0% | 127 | +273.5% | 0.00% | +200.0% |
Q3 2020 | $2,000 | +100.0% | 34 | +21.4% | 0.00% | – |
Q2 2020 | $1,000 | – | 28 | +180.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 10 | -79.6% | 0.00% | -100.0% |
Q4 2019 | $2,000 | -66.7% | 49 | -59.8% | 0.00% | -66.7% |
Q1 2016 | $6,000 | – | 122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |